Last Updated on December 24, 2023 by The Health Master
Alembic Pharmaceuticals Limited has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for dabigatran etexilate capsules, 75 mg, 110 mg, and 150 mg.
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim Pharmaceuticals, Inc. (Boehringer).
Dabigatran etexilate capsules, are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients, treatment of deep venous thrombosis and pulmonary embolism in adult patients, reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism in adult patients, prophylaxis of deep vein thrombosis and pulmonary embolism in adult patients following hip replacement surgery.
It may not be indicated for certain other uses due to unexpired exclusivities for the RLD for such uses.
Dabigatran etexilate capsules, 75 mg, 110 mg, and 150 mg have an estimated market size of US$ 465 million for twelve months ending December 2021 according to IQVIA.
Alembic has received a cumulative total of 162 ANDA approvals (139 final approvals and 23 tentative approvals) from US FDA.
USFDA approves Cell Therapy for earlier lymphoma
USFDA approves Ozempic 2 mg to treat Type-II Diabetes
USFDA gives nod to Lupin for Sildenafil for oral suspension
USFDA gives approval to Glenmark Pharma for Lacosamide Tablets
USFDA approves drug for treatment of Seizures associated with rare disease
USFDA approves new Bristol Myers cancer Immunotherapy
USFDA issues 4 Observations to Lupin for Tarapur Facility
Dr Reddy’s launches generic Methylprednisolone Sodium Succinate for injection
Certain Products recalled due to Microbial Contamination
USFDA approves Cell Therapy for earlier lymphoma
Drug Recall: IDArubicin Hydrochloride Injection recalled due to this reason
USFDA gives 13 observations to Lupin
Govt further extends timeline to apply for slots under PLI scheme
CDSCO panel gives nod to Roche for Anticancer Drug Entrectinib Capsules
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
